Your browser doesn't support javascript.
loading
Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report.
Spurdle, Amanda B; Greville-Heygate, Stephanie; Antoniou, Antonis C; Brown, Melissa; Burke, Leslie; de la Hoya, Miguel; Domchek, Susan; Dörk, Thilo; Firth, Helen V; Monteiro, Alvaro N; Mensenkamp, Arjen; Parsons, Michael T; Radice, Paolo; Robson, Mark; Tischkowitz, Marc; Tudini, Emma; Turnbull, Clare; Vreeswijk, Maaike Pg; Walker, Logan C; Tavtigian, Sean; Eccles, Diana M.
Afiliación
  • Spurdle AB; Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Greville-Heygate S; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Antoniou AC; Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  • Brown M; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia.
  • Burke L; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia.
  • de la Hoya M; Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.
  • Domchek S; Basser Center for BRCA, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Firth HV; Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK.
  • Monteiro AN; Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Mensenkamp A; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Parsons MT; Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Radice P; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Robson M; Clinical Genetics Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Tischkowitz M; Department of Medical Genetics, Cambridge University, Cambridge, UK.
  • Tudini E; Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Turnbull C; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
  • Vreeswijk MP; William Harvey Research Institute, Queen Mary Hospital, London, UK.
  • Walker LC; Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Tavtigian S; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
  • Eccles DM; Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA.
J Med Genet ; 56(6): 347-357, 2019 06.
Article en En | MEDLINE | ID: mdl-30962250
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Variación Genética / Clasificación Internacional de Enfermedades / Neoplasias de Células Germinales y Embrionarias / Predisposición Genética a la Enfermedad Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Med Genet Año: 2019 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Variación Genética / Clasificación Internacional de Enfermedades / Neoplasias de Células Germinales y Embrionarias / Predisposición Genética a la Enfermedad Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Med Genet Año: 2019 Tipo del documento: Article País de afiliación: Australia